-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
White Pine Capital LLC Purchases 38,030 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)
White Pine Capital LLC Purchases 38,030 Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII)
White Pine Capital LLC increased its position in Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 217.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,534 shares of the medical device company's stock after purchasing an additional 38,030 shares during the quarter. White Pine Capital LLC owned approximately 0.14% of Cardiovascular Systems worth $1,255,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of CSII. Champlain Investment Partners LLC increased its holdings in shares of Cardiovascular Systems by 5.0% in the 4th quarter. Champlain Investment Partners LLC now owns 3,488,625 shares of the medical device company's stock valued at $65,516,000 after acquiring an additional 167,105 shares during the period. Cubist Systematic Strategies LLC increased its holdings in shares of Cardiovascular Systems by 1,124.7% in the 4th quarter. Cubist Systematic Strategies LLC now owns 176,858 shares of the medical device company's stock valued at $3,321,000 after acquiring an additional 162,417 shares during the period. Grandeur Peak Global Advisors LLC boosted its position in shares of Cardiovascular Systems by 36.2% in the 4th quarter. Grandeur Peak Global Advisors LLC now owns 564,582 shares of the medical device company's stock worth $10,603,000 after purchasing an additional 150,103 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Cardiovascular Systems by 344.6% in the 4th quarter. BNP Paribas Arbitrage SA now owns 171,228 shares of the medical device company's stock worth $3,216,000 after purchasing an additional 132,716 shares in the last quarter. Finally, Walleye Capital LLC boosted its position in shares of Cardiovascular Systems by 185.5% in the 4th quarter. Walleye Capital LLC now owns 200,015 shares of the medical device company's stock worth $3,756,000 after purchasing an additional 129,967 shares in the last quarter. Institutional investors own 91.72% of the company's stock.
Get Cardiovascular Systems alerts:Cardiovascular Systems Stock Down 1.1 %
NASDAQ CSII traded down $0.14 during trading on Thursday, hitting $13.07. The company's stock had a trading volume of 6,021 shares, compared to its average volume of 355,137. The company has a debt-to-equity ratio of 0.08, a current ratio of 6.05 and a quick ratio of 5.19. The company has a market cap of $535.41 million, a PE ratio of -13.91 and a beta of 0.94. The business's 50 day simple moving average is $15.34 and its 200-day simple moving average is $17.53. Cardiovascular Systems, Inc. has a fifty-two week low of $13.21 and a fifty-two week high of $37.58.
Cardiovascular Systems Profile
(Get Rating)Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
Featured Stories
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- How will the chip ban affect Nvidia's stock?
- Is Best Buy A Sneaky Buy for Q4?
- Does The Bed Bath and Beyond Stock Rally Still Have Legs?
- Can Alibaba And Baidu Finally Rally With Delisting Fears Gone?
- 3 Materials Stocks That May Earn a Place on Your Watchlist
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
White Pine Capital LLC increased its position in Cardiovascular Systems, Inc. (NASDAQ:CSII – Get Rating) by 217.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,534 shares of the medical device company's stock after purchasing an additional 38,030 shares during the quarter. White Pine Capital LLC owned approximately 0.14% of Cardiovascular Systems worth $1,255,000 as of its most recent SEC filing.
根據白松資本公司最近向美國證券交易委員會披露的信息,該公司第一季度將其在心血管系統公司(納斯達克代碼:CSII-GET評級)的股份增加了217.3%。該機構投資者在本季度額外購買了38,030股票後,持有這家醫療器械公司的55,534股票。截至其最近提交的美國證券交易委員會申請文件,White Pine Capital LLC擁有心血管系統公司約0.14%的股份,價值125.5萬美元。
Several other hedge funds and other institutional investors also recently bought and sold shares of CSII. Champlain Investment Partners LLC increased its holdings in shares of Cardiovascular Systems by 5.0% in the 4th quarter. Champlain Investment Partners LLC now owns 3,488,625 shares of the medical device company's stock valued at $65,516,000 after acquiring an additional 167,105 shares during the period. Cubist Systematic Strategies LLC increased its holdings in shares of Cardiovascular Systems by 1,124.7% in the 4th quarter. Cubist Systematic Strategies LLC now owns 176,858 shares of the medical device company's stock valued at $3,321,000 after acquiring an additional 162,417 shares during the period. Grandeur Peak Global Advisors LLC boosted its position in shares of Cardiovascular Systems by 36.2% in the 4th quarter. Grandeur Peak Global Advisors LLC now owns 564,582 shares of the medical device company's stock worth $10,603,000 after purchasing an additional 150,103 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Cardiovascular Systems by 344.6% in the 4th quarter. BNP Paribas Arbitrage SA now owns 171,228 shares of the medical device company's stock worth $3,216,000 after purchasing an additional 132,716 shares in the last quarter. Finally, Walleye Capital LLC boosted its position in shares of Cardiovascular Systems by 185.5% in the 4th quarter. Walleye Capital LLC now owns 200,015 shares of the medical device company's stock worth $3,756,000 after purchasing an additional 129,967 shares in the last quarter. Institutional investors own 91.72% of the company's stock.
其他幾家對衝基金和其他機構投資者最近也買賣了CSII的股票。尚普蘭投資夥伴有限責任公司在第四季度增持了心血管系統公司的股票5.0%。尚普蘭投資夥伴有限責任公司現在擁有這家醫療器械公司3,488,625股股票,價值65,516,000美元,在此期間又購買了167,105股票。Cubist Systems Strategy LLC在第四季度增持了心血管系統公司的股票1124.7%。Cubist Systems Strategy LLC在此期間額外收購了162,417股,現在擁有176,858股這家醫療器械公司的股票,價值3,321,000美元。宏偉的Peak Global Advisors LLC在第四季度將其在心血管系統公司的股票份額增加了36.2%。宏偉的Peak Global Advisors LLC現在持有這家醫療設備公司564,582股股票,價值10,603,000美元,上個季度又購買了150,103股。法國巴黎銀行套利公司在第四季度將其在心血管系統公司的股票頭寸提高了344.6%。法國巴黎銀行套利公司現在擁有171,228股這家醫療設備公司的股票,價值321.6萬美元,上個季度又購買了132,716股。最後,Walleye Capital LLC在第四季度將其在心血管系統公司的股票頭寸增加了185.5%。Walleye Capital LLC現在持有這家醫療設備公司200,015股股票,價值3756,000美元,上個季度又購買了129,967股。機構投資者持有該公司91.72%的股票。
Cardiovascular Systems Stock Down 1.1 %
心血管系統類股下跌1.1%
NASDAQ CSII traded down $0.14 during trading on Thursday, hitting $13.07. The company's stock had a trading volume of 6,021 shares, compared to its average volume of 355,137. The company has a debt-to-equity ratio of 0.08, a current ratio of 6.05 and a quick ratio of 5.19. The company has a market cap of $535.41 million, a PE ratio of -13.91 and a beta of 0.94. The business's 50 day simple moving average is $15.34 and its 200-day simple moving average is $17.53. Cardiovascular Systems, Inc. has a fifty-two week low of $13.21 and a fifty-two week high of $37.58.
在週四的交易中,納斯達克中證股價下跌0.14美元,至13.07美元。該公司股票的成交量為6,021股,而其平均成交量為355,137股。該公司的負債權益比為0.08,流動比率為6.05,速動比率為5.19。該公司市值為5.3541億美元,市盈率為-13.91,貝塔係數為0.94。該業務的50日簡單移動均線切入位在15.34美元,200日簡單移動均線切入位在17.53美元。心血管系統公司的股價跌至52周低點13.21美元和52周高點37.58美元。
Cardiovascular Systems Profile
心血管系統概況
Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.
心血管系統公司是一家醫療設備公司,在美國和國際上開發和銷售治療外周和冠狀動脈疾病的解決方案。該公司提供外周動脈疾病產品,這是基於導管的平臺,用於治療膝蓋以上和膝蓋以下的各種斑塊類型,包括鈣化斑塊,以及解決與手術、導管和藥物治療替代方案相關的各種限制;以及外周支持產品。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)
- How will the chip ban affect Nvidia's stock?
- Is Best Buy A Sneaky Buy for Q4?
- Does The Bed Bath and Beyond Stock Rally Still Have Legs?
- Can Alibaba And Baidu Finally Rally With Delisting Fears Gone?
- 3 Materials Stocks That May Earn a Place on Your Watchlist
- 免費獲取StockNews.com心血管系統研究報告(CSII)
- 芯片禁令將如何影響NVIDIA的股票?
- 百思買是第四季度的Sneaky Buy嗎?
- Bed Bath和Beyond Stock Rally還有腿嗎?
- 阿里巴巴-SW和百度集團-SW最終能在退市恐懼中重整旗鼓嗎?
- 3種可能在你的觀察名單上獲得一席之地的材料類股
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受《每日心血管系統》新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對心血管系統和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧